Literature DB >> 637638

Incidence of pituitary tumors following adrenalectomy. A long-term follow-up study of patients treated for Cushing's disease.

K L Cohen, R H Noth, T Pechinski.   

Abstract

The long-term follow-up of 21 patients who had undergone bilateral adrenalectomy for Cushing's disease has revealed eight definite and two suspected cases of pituitary tumors. The average time from adrenalectomy to the diagnosis of the pituitary tumor was 6 1/2 years, with a range of 1 1/2 to 12 years. The incidence of tumors in this study (38%) is higher than that reported by others and may reflect (1) that none of these patients received pituitary irradiation in addition to adrenalectomy, (2) the length of follow-up, and (3) the high index of suspicion and early diagnosis of pituitary tumors in recent years. These data raise the question of whether bilateral adrenalectomy alone is an acceptable form of therapy for Cushing's disease. For patients treated in this way, a life-long commitment should be made to undergo annual reexamination for the possible occurrence of a pituitary neoplasm.

Entities:  

Mesh:

Year:  1978        PMID: 637638     DOI: 10.1001/archinte.138.4.575

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  11 in total

1.  Complications following adrenal surgery.

Authors:  M K McLeod
Journal:  J Natl Med Assoc       Date:  1991-02       Impact factor: 1.798

2.  The pituitary before and after adrenalectomy for Cushing's syndrome.

Authors:  K J Manolas; H M Farmer; H K Wilson; A L Kennedy; G F Joplin; D A Montgomery; T L Kennedy; R B Welbourn
Journal:  World J Surg       Date:  1984-06       Impact factor: 3.352

Review 3.  The Nelson's syndrome... revisited.

Authors:  Guillaume Assié; Hélène Bahurel; Jérôme Bertherat; Michèle Kujas; Paul Legmann; Xavier Bertagna
Journal:  Pituitary       Date:  2004       Impact factor: 4.107

4.  In-vitro secretion of ACTH in Nelson's syndrome.

Authors:  D K Lüdecke; M Schabet; M Westphal; W Saeger
Journal:  Acta Neurochir (Wien)       Date:  1982       Impact factor: 2.216

5.  Pituitary function before and after transsphenoidal adenomectomy in patients with Cushing's disease.

Authors:  B Ambrosi; M Giovanelli; S M Gaini; D Bochicchio; E Riva; G Tomei; M Zavanone; G Faglia
Journal:  Acta Neurochir (Wien)       Date:  1982       Impact factor: 2.216

6.  Complete remission of Nelson's syndrome after 1-year treatment with cabergoline.

Authors:  R Pivonello; A Faggiano; F Di Salle; M Filippella; G Lombardi; A Colao
Journal:  J Endocrinol Invest       Date:  1999-12       Impact factor: 4.256

7.  Bilateral adrenalectomy for Cushing's syndrome. Anterior versus posterior surgical approach.

Authors:  J F Buell; H R Alexander; J A Norton; K C Yu; D L Fraker
Journal:  Ann Surg       Date:  1997-01       Impact factor: 12.969

8.  Evaluation of surgically treated Nelson's syndrome.

Authors:  D K Lüdecke; H J Breustedt; J Brämswig; J Köbberling; W Saeger
Journal:  Acta Neurochir (Wien)       Date:  1982       Impact factor: 2.216

9.  Trans-sphenoidal microsurgical treatment of Nelson's syndrome.

Authors:  T Fukushima
Journal:  Neurosurg Rev       Date:  1985       Impact factor: 3.042

10.  Corticotroph tumor progression after bilateral adrenalectomy (Nelson's syndrome): systematic review and expert consensus recommendations.

Authors:  Martin Reincke; Adriana Albani; Guillaume Assie; Irina Bancos; Thierry Brue; Michael Buchfelder; Olivier Chabre; Filippo Ceccato; Andrea Daniele; Mario Detomas; Guido Di Dalmazi; Atanaska Elenkova; James Findling; Ashley B Grossman; Celso E Gomez-Sanchez; Anthony P Heaney; Juergen Honegger; Niki Karavitaki; Andre Lacroix; Edward R Laws; Marco Losa; Masanori Murakami; John Newell-Price; Francesca Pecori Giraldi; Luis G Pérez-Rivas; Rosario Pivonello; William E Rainey; Silviu Sbiera; Jochen Schopohl; Constantine A Stratakis; Marily Theodoropoulou; Elisabeth F C van Rossum; Elena Valassi; Sabina Zacharieva; German Rubinstein; Katrin Ritzel
Journal:  Eur J Endocrinol       Date:  2021-03       Impact factor: 6.664

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.